Valneva confirms clinical trial and regulatory submission timelines for its inactivated COVID-19 vaccine candidate VLA2001
7 January 2022Valneva, a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials and regulatory submissions for its... View Article